NCT00643097 arm group ad28360f4f45c70c5356dc3970cdd6c8 [clinicaltrials_resource:NCT00643097/arm-group/ad28360f4f45c70c5356dc3970cdd6c8]
NCT00643097 arm group ad28360f4f45c70c5356dc3970cdd6c8 [clinicaltrials_resource:NCT00643097/arm-group/ad28360f4f45c70c5356dc3970cdd6c8]
Bio2RDF identifier
NCT00643097/arm-group/ad28360f4f45c70c5356dc3970cdd6c8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 28360f4f45c70c5356dc3970cdd6c8
description [clinicaltrials_vocabulary:description]
Patients first receive 3 initi ...... rst 21 days of a 28 day cycle.
identifier
clinicaltrials_resource:NCT00643097/arm-group/ad28360f4f45c70c5356dc3970cdd6c8
title
NCT00643097 arm group ad28360f4f45c70c5356dc3970cdd6c8
@en
type
label
NCT00643097 arm group ad28360f ...... 8360f4f45c70c5356dc3970cdd6c8]
@en